NIH funds four clinical trials to fight antimicrobial resistance

NIH funds four clinical trials to fight antimicrobial resistance
Eight large NIH trials now seeking to preserve the usefulness of licensed antibiotics

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new contracts for large-scale clinical trials that address the problem of antimicrobial resistance. Over the next five to six years, these new clinical trials will evaluate treatment alternatives for diseases for which antibiotics are prescribed most often, including acute otitis media (middle ear infections), community-acquired pneumonia and diseases caused by Gram-negative bacteria, which frequently are resistant to first-line antibiotics. Each trial will enroll at least 1,000 participants who have been diagnosed with these illnesses and diseases.

For more information, go to http://www.niaid.nih.gov/news/newsreleases/2010/Pages/ARtrialsAwards.aspx.

You are subscribed to News Releases for National Institute of Allergy and Infectious Diseases. This information has recently been updated, and is now available.

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

GovDelivery, Inc. sending on behalf of National Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda MD 20892 · 866-284-4107